Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
- Conditions
- Perennial Allergic RhinitisAllergic RhinitisNon-seasonal Allergic Rhinitis
- Interventions
- Drug: AGR tabletDrug: Placebo (for AGR tablet and/or Active Comparator)Drug: Active Comparator
- Registration Number
- NCT01982916
- Lead Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Brief Summary
The purpose of this study is to evaluate treatment of perennial allergic rhinitis in Korean patients with AGR tablet.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 324
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description AGR & Placebo AGR tablet AGR tablet by qd and Placebo by bid for 4 weeks AGR & Placebo Placebo (for AGR tablet and/or Active Comparator) AGR tablet by qd and Placebo by bid for 4 weeks Active comparator Placebo (for AGR tablet and/or Active Comparator) Active Comparator and Placebo by bid for 4 weeks Active comparator Active Comparator Active Comparator and Placebo by bid for 4 weeks Placebo Placebo (for AGR tablet and/or Active Comparator) Placebo by bid for 4 weeks
- Primary Outcome Measures
Name Time Method Change of 4NTSS(4 Nasal Total Symptoms score) from baseline 4 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (9)
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of
Seoul National University Bundang Hospital
🇰🇷Seongnam, Gyeonggi-do, Korea, Republic of
Inha University Hospital
🇰🇷Incheon, Korea, Republic of
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of
Kyung Hee University Medical Center
🇰🇷Seoul, Korea, Republic of
Severance Hospital
🇰🇷Seoul, Korea, Republic of
Seoul St. Mary's Hospital
🇰🇷Seoul, Korea, Republic of
Konkuk University Medical Center
🇰🇷Seoul, Korea, Republic of
SMG-SNU Boramae Medical Center
🇰🇷Seoul, Korea, Republic of